Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.08    -0.11 (-1.34%)
Bid:
8.00
Ask:
8.19
Spread: 0.19 (2.375%)
Market Cap: £93.39m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Director/PDMR Shareholding

1 Oct 2025 09:00

RNS Number : 4755B
SIG PLC
01 October 2025
 

LEI: 213800VDC1BKJEZ8PV53 1 October 2025

 

SIG plc

 

("SIG" or the "Company")

 

PDMR Shareholding/Appointment of director

 

Notification and public disclosure of the grant of a recruitment restricted share award to Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

SIG plc announces that, following its announcement of 8 July, Pim Vervaat has today been appointed a director of the Company, Group Chief Executive Officer and Chair designate. As also announced on 8 July, Pim has today been granted a one-off recruitment restricted share award over the Company's Ordinary Shares of 10 pence each ("Shares") on the terms set out in the shareholder circular dated 5 August 2025 (the "Award"). The making of the Award was approved by shareholders at the general meeting on 28 August.

 

Name

Status

Number of Shares under the Award

Option Price

Pim Vervaat

Chief Executive Officer and Chair designate

14,674,121

£Nil

 

The vesting date for the Award is 1 April 2027. Once vested, the Award will be exercisable until the day before the tenth anniversary of the Award date. The Shares that are the subject of the Award are subject to a minimum holding period which ends on the later of (i) the fifth anniversary of the date of grant, and (ii) the date on which he ceases to be a director of the Company (including as non-executive Chair). No consideration was paid for the grant of the Award which is structured as a nil cost option.

 

In addition to the Shares that are the subject of the Award, Pim has purchased, as beneficial owner, 2,500,000 Shares since the announcement of his appointment on 8 July. He has committed to hold these Shares at least until the date that the Award vests (or, if earlier, lapses).

 

This announcement and the following disclosures are made in accordance with Article 19 of the UK Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Pim Vervaat

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer and Chair designate)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SIG plc

b)

LEI

213800VDC1BKJEZ8PV53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

b)

Nature of the transaction

Grant of a one-off recruitment restricted share award for nil consideration

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

GBP Nil

14,674,121

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

1 October 2025

f)

Place of the transaction

Outside a trading venue

 

 

Enquiries:

 

 

 

 

SIG plc

 

 

Andrew Watkins

Group General Counsel & Company Secretary

+44 (0) 114 285 6300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDIFISEISEDU
Date   Source Headline
8th Jun 20264:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.